#METABOLOMICS WORKBENCH michaelsa93_20170719_105604 DATATRACK_ID:1151 STUDY_ID:ST000800 ANALYSIS_ID:AN001272 PROJECT_ID:PR000576
VERSION             	1
CREATED_ON             	July 20, 2017, 12:56 pm
#PROJECT
PR:PROJECT_TITLE                 	Insights into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
PR:PROJECT_TITLE                 	phenotypes through comprehensive metabolomics
PR:PROJECT_SUMMARY               	The pathogenesis of ME/CFS, a disease characterized by unexplained debilitating
PR:PROJECT_SUMMARY               	fatigue, cognitive dysfunction, sleep disturbances, orthostatic intolerance,
PR:PROJECT_SUMMARY               	fever, lymphadenopathy and irritable bowel syndrome (IBS), is poorly understood.
PR:PROJECT_SUMMARY               	There are no validated diagnostic tests or interventions to mitigate disease.
PR:PROJECT_SUMMARY               	Here we report association modeling, biomarker discovery, biochemical enrichment
PR:PROJECT_SUMMARY               	analysis and topological network visualization of plasma metabolomic, fecal
PR:PROJECT_SUMMARY               	bacterial metagenomic and clinical data from 50 ME/CFS patients and 50 healthy
PR:PROJECT_SUMMARY               	controls.
PR:INSTITUTE                     	Columbia University
PR:DEPARTMENT                    	Center for Infection and Immunity, Mailman School of Public Health
PR:LAST_NAME                     	Lipkin
PR:FIRST_NAME                    	Ian
PR:ADDRESS                       	722 West 168th Street, Room 1703a, New York, NY USA 10032
PR:EMAIL                         	wil2001@columbia.edu
PR:PHONE                         	212-342-9044
#STUDY
ST:STUDY_TITLE                   	Insights into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
ST:STUDY_TITLE                   	phenotypes through comprehensive metabolomics
ST:STUDY_TYPE                    	Observational
ST:STUDY_SUMMARY                 	The pathogenesis of ME/CFS, a disease characterized by unexplained debilitating
ST:STUDY_SUMMARY                 	fatigue, cognitive dysfunction, sleep disturbances, orthostatic intolerance,
ST:STUDY_SUMMARY                 	fever, lymphadenopathy and irritable bowel syndrome (IBS), is poorly understood.
ST:STUDY_SUMMARY                 	There are no validated diagnostic tests or interventions to mitigate disease.
ST:STUDY_SUMMARY                 	Here we report association modeling, biomarker discovery, biochemical enrichment
ST:STUDY_SUMMARY                 	analysis and topological network visualization of plasma metabolomic, fecal
ST:STUDY_SUMMARY                 	bacterial metagenomic and clinical data from 50 ME/CFS patients and 50 healthy
ST:STUDY_SUMMARY                 	controls. Through targeted and untargeted metabolomics analyses we confirm
ST:STUDY_SUMMARY                 	earlier reports of specific alterations in plasma levels of choline, carnitine
ST:STUDY_SUMMARY                 	and complex lipid metabolism in ME/CFS. We also demonstrate that patients with
ST:STUDY_SUMMARY                 	ME/CFS and IBS have a unique metabolomic profile that includes increased plasma
ST:STUDY_SUMMARY                 	levels of ceramide, a waxy lipid implicated in suppression of electron
ST:STUDY_SUMMARY                 	transport, insulin and leptin resistance and apoptosis. Integration of fecal
ST:STUDY_SUMMARY                 	metagenomic and plasma metabolomic data resulted in a stronger predictive model
ST:STUDY_SUMMARY                 	of ME/CFS (cross-validated AUC=0.836) than either metagenomic (cross-validated
ST:STUDY_SUMMARY                 	AUC=0.745) or metabolomic (cross-validated AUC=0.820) analysis alone. Our
ST:STUDY_SUMMARY                 	findings may provide insights into the pathogenesis of ME/CFS and ME/CFS
ST:STUDY_SUMMARY                 	subtypes, and suggest pathways for the development of diagnostic and therapeutic
ST:STUDY_SUMMARY                 	strategies.
ST:INSTITUTE                     	University of California, Davis
ST:DEPARTMENT                    	Genome and Biomedical Sciences Facility
ST:LABORATORY                    	WCMC Metabolomics Core
ST:LAST_NAME                     	Fiehn
ST:FIRST_NAME                    	Oliver
ST:ADDRESS                       	1315 Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, Davis,
ST:ADDRESS                       	CA 95616
ST:EMAIL                         	ofiehn@ucdavis.edu
ST:PHONE                         	(530) 754-8258
ST:STUDY_COMMENTS                	Key: mecfs : 1 in this column indicates case, while 0 indicates control Ibs: 1
ST:STUDY_COMMENTS                	in this column indicates the patient does have disease, 0 indicates free of ibs
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	Biorec003_CSH_tLipkin020.d	Biorec003	CaseStatus:- | SEX:- | AGE_DICH:-	BMI_DICH=-; height (in.)=-; weight (lbs.)=-; bmi=-; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Biorec004_CSH_tLipkin030.d	Biorec004	CaseStatus:- | SEX:- | AGE_DICH:-	BMI_DICH=-; height (in.)=-; weight (lbs.)=-; bmi=-; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Biorec005_CSH_tLipkin040.d	Biorec005	CaseStatus:- | SEX:- | AGE_DICH:-	BMI_DICH=-; height (in.)=-; weight (lbs.)=-; bmi=-; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Biorec006_CSH_tLipkin050.d	Biorec006	CaseStatus:- | SEX:- | AGE_DICH:-	BMI_DICH=-; height (in.)=-; weight (lbs.)=-; bmi=-; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Biorec007_CSH_tLipkin060.d	Biorec007	CaseStatus:- | SEX:- | AGE_DICH:-	BMI_DICH=-; height (in.)=-; weight (lbs.)=-; bmi=-; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Biorec010_CSH_tLipkin090.d	Biorec010	CaseStatus:- | SEX:- | AGE_DICH:-	BMI_DICH=-; height (in.)=-; weight (lbs.)=-; bmi=-; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Biorec011_CSH_tLipkin0102.d	Biorec011	CaseStatus:- | SEX:- | AGE_DICH:-	BMI_DICH=-; height (in.)=-; weight (lbs.)=-; bmi=-; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin072_CSH_ESP-0007_001.d	ESP-0007	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=70; weight (lbs.)=154; bmi=22.09; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin085_CSH_ESP-0020_002.d	ESP-0020	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=70; weight (lbs.)=230; bmi=33; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin027_CSH_ESP-0033_003.d	ESP-0033	CaseStatus:Case | SEX:Male | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=75; weight (lbs.)=252; bmi=31.49; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin081_CSH_ESP-0046_004.d	ESP-0046	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=61; weight (lbs.)=148; bmi=27.96; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin034_CSH_ESP-0059_005.d	ESP-0059	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=68; weight (lbs.)=140; bmi=21.28; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin065_CSH_ESP-0072_006.d	ESP-0072	CaseStatus:Case | SEX:Male | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=76; weight (lbs.)=206; bmi=25.07; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin029_CSH_ESP-0085_007.d	ESP-0085	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=175; bmi=30.04; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin048_CSH_ESP-0098_008.d	ESP-0098	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=58; weight (lbs.)=130; bmi=27.17; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin047_CSH_ESP-0111_009.d	ESP-0111	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=67; weight (lbs.)=165.4; bmi=25.9; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin069_CSH_ESP-0124_010.d	ESP-0124	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=65; weight (lbs.)=143; bmi=23.79; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin038_CSH_ESP-0137_011.d	ESP-0137	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=72; weight (lbs.)=147; bmi=19.93; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin050_CSH_ESP-0150_012.d	ESP-0150	CaseStatus:Control | SEX:Male | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=68; weight (lbs.)=158; bmi=24.02; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin096_CSH_ESP-0163_013.d	ESP-0163	CaseStatus:Control | SEX:Male | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=72; weight (lbs.)=178; bmi=24.14; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin037_CSH_ESP-0176_014.d	ESP-0176	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=67; weight (lbs.)=125; bmi=19.58; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin049_CSH_ESP-0189_015.d	ESP-0189	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=200; bmi=34.33; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin063_CSH_ESP-0202_016.d	ESP-0202	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=62; weight (lbs.)=140; bmi=25.6; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin083_CSH_ESP-0215_017.d	ESP-0215	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=150; bmi=25.74; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin057_CSH_ESP-0228_018.d	ESP-0228	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=64; weight (lbs.)=124.6; bmi=21.39; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin074_CSH_ESP-0241_019.d	ESP-0241	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=62.5; weight (lbs.)=180; bmi=32.39; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin062_CSH_ESP-0254_020.d	ESP-0254	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=64; weight (lbs.)=118; bmi=20.25; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin076_CSH_ESP-0267_021.d	ESP-0267	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=63; weight (lbs.)=156; bmi=27.63; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin101_CSH_ESP-0280_022.d	ESP-0280	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=69; weight (lbs.)=207; bmi=30.57; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin039_CSH_ESP-0293_023.d	ESP-0293	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=61; weight (lbs.)=160; bmi=30.23; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin056_CSH_ESP-0306_024.d	ESP-0306	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=67; weight (lbs.)=230; bmi=36.02; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin064_CSH_ESP-0319_025.d	ESP-0319	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=62; weight (lbs.)=120; bmi=21.95; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin095_CSH_ESP-0332_026.d	ESP-0332	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=68.5; weight (lbs.)=140.5; bmi=21.05; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin013_CSH_ESP-0345_027.d	ESP-0345	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=67; weight (lbs.)=145; bmi=22.71; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin017_CSH_ESP-0358_028.d	ESP-0358	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=65; weight (lbs.)=128.8; bmi=21.43; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin002_CSH_ESP-0371_029.d	ESP-0371	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=62; weight (lbs.)=231; bmi=42.25; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin001_CSH_ESP-0384_030.d	ESP-0384	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=65; weight (lbs.)=159; bmi=26.46; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin021_CSH_ESP-0397_031.d	ESP-0397	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=71; weight (lbs.)=149; bmi=20.78; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin044_CSH_ESP-0410_032.d	ESP-0410	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=60; weight (lbs.)=157.4; bmi=30.74; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin032_CSH_ESP-0423_033.d	ESP-0423	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=166.4; bmi=28.56; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin094_CSH_ESP-0436_034.d	ESP-0436	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=63; weight (lbs.)=122; bmi=21.61; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin042_CSH_ESP-0449_035.d	ESP-0449	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=63; weight (lbs.)=170; bmi=30.11; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin007_CSH_ESP-0462_036.d	ESP-0462	CaseStatus:Case | SEX:Male | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=68; weight (lbs.)=189; bmi=28.73; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin082_CSH_ESP-0475_037.d	ESP-0475	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=64; weight (lbs.)=142; bmi=24.37; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin004_CSH_ESP-0488_038.d	ESP-0488	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=63; weight (lbs.)=150; bmi=26.57; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin024_CSH_ESP-0501_039.d	ESP-0501	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=160; bmi=27.46; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin073_CSH_ESP-0514_040.d	ESP-0514	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=65; weight (lbs.)=144; bmi=23.96; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin033_CSH_ESP-0527_041.d	ESP-0527	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=65; weight (lbs.)=120; bmi=19.97; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin019_CSH_ESP-0540_042.d	ESP-0540	CaseStatus:Control | SEX:Male | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=72; weight (lbs.)=160; bmi=21.7; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin071_CSH_ESP-0553_043.d	ESP-0553	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=153; bmi=26.26; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin005_CSH_ESP-0566_044.d	ESP-0566	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=68; weight (lbs.)=168; bmi=25.54; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin053_CSH_ESP-0579_045.d	ESP-0579	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=65; weight (lbs.)=135; bmi=22.46; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin035_CSH_ESP-0592_046.d	ESP-0592	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=150; bmi=25.74; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin089_CSH_ESP-0605_047.d	ESP-0605	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=61; weight (lbs.)=96.6; bmi=18.25; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin043_CSH_ESP-0618_048.d	ESP-0618	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=61; weight (lbs.)=120; bmi=22.67; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin023_CSH_ESP-0631_049.d	ESP-0631	CaseStatus:Control | SEX:Male | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=72; weight (lbs.)=194; bmi=26.31; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin020_CSH_ESP-0644_050.d	ESP-0644	CaseStatus:Case | SEX:Male | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=67.5; weight (lbs.)=160; bmi=24.69; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin092_CSH_ESP-0657_051.d	ESP-0657	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=61; weight (lbs.)=137.8; bmi=26.03; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin009_CSH_ESP-0670_052.d	ESP-0670	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=63; weight (lbs.)=175.8; bmi=31.14; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin040_CSH_ESP-0683_053.d	ESP-0683	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=67; weight (lbs.)=125; bmi=19.58; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin012_CSH_ESP-0696_054.d	ESP-0696	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=67; weight (lbs.)=194.6; bmi=30.48; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin080_CSH_ESP-0709_055.d	ESP-0709	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=63; weight (lbs.)=132; bmi=23.38; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin028_CSH_ESP-0722_056.d	ESP-0722	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=66; weight (lbs.)=205; bmi=33.08; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin077_CSH_ESP-0735_057.d	ESP-0735	CaseStatus:Control | SEX:Male | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=71; weight (lbs.)=175; bmi=24.4; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin099_CSH_ESP-0748_058.d	ESP-0748	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=65; weight (lbs.)=130; bmi=21.63; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin054_CSH_ESP-0761_059.d	ESP-0761	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=58.8; weight (lbs.)=115; bmi=23.38; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin088_CSH_ESP-0774_060.d	ESP-0774	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=66; weight (lbs.)=138; bmi=22.27; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin097_CSH_ESP-0787_061.d	ESP-0787	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=158; bmi=27.12; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin078_CSH_ESP-0800_062.d	ESP-0800	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=66; weight (lbs.)=138; bmi=22.27; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin008_CSH_ESP-0813_063.d	ESP-0813	CaseStatus:Case | SEX:Male | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=70; weight (lbs.)=185; bmi=26.54; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin066_CSH_ESP-0826_064.d	ESP-0826	CaseStatus:Case | SEX:Male | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=67; weight (lbs.)=195; bmi=30.54; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin018_CSH_ESP-0839_065.d	ESP-0839	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=72; weight (lbs.)=179; bmi=24.27; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin058_CSH_ESP-0852_066.d	ESP-0852	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=68; weight (lbs.)=217; bmi=32.99; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin016_CSH_ESP-0865_067.d	ESP-0865	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=65; weight (lbs.)=124; bmi=20.63; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin051_CSH_ESP-0878_068.d	ESP-0878	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=67; weight (lbs.)=192.2; bmi=30.1; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin068_CSH_ESP-0891_069.d	ESP-0891	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=63.5; weight (lbs.)=219; bmi=38.18; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin011_CSH_ESP-0904_070.d	ESP-0904	CaseStatus:Case | SEX:Male | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=68; weight (lbs.)=164; bmi=24.93; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin059_CSH_ESP-0917_071.d	ESP-0917	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=65; weight (lbs.)=178; bmi=29.62; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin014_CSH_ESP-0930_072.d	ESP-0930	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=66; weight (lbs.)=140; bmi=22.59; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin100_CSH_ESP-0943_073.d	ESP-0943	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=68; weight (lbs.)=150; bmi=22.8; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin046_CSH_ESP-0956_074.d	ESP-0956	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=61; weight (lbs.)=146; bmi=27.58; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin060_CSH_ESP-0969_075.d	ESP-0969	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=62; weight (lbs.)=136; bmi=24.87; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin075_CSH_ESP-0982_076.d	ESP-0982	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=66; weight (lbs.)=154; bmi=24.85; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin093_CSH_ESP-0995_077.d	ESP-0995	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=67.5; weight (lbs.)=140; bmi=21.6; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin086_CSH_ESP-1008_078.d	ESP-1008	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=60; weight (lbs.)=140; bmi=27.34; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin067_CSH_ESP-1021_079.d	ESP-1021	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=64; weight (lbs.)=135; bmi=23.17; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin091_CSH_ESP-1034_080.d	ESP-1034	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=218; bmi=37.42; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin055_CSH_ESP-1047_081.d	ESP-1047	CaseStatus:Case | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=62; weight (lbs.)=115; bmi=21.03; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin070_CSH_ESP-1060_082.d	ESP-1060	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=64; weight (lbs.)=130; bmi=22.31; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin003_CSH_ESP-1073_083.d	ESP-1073	CaseStatus:Control | SEX:Male | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=65; weight (lbs.)=180; bmi=29.95; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin006_CSH_ESP-1086_084.d	ESP-1086	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=68; weight (lbs.)=143; bmi=21.74; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin045_CSH_ESP-1099_085.d	ESP-1099	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=61; weight (lbs.)=120; bmi=22.67; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin031_CSH_ESP-1112_086.d	ESP-1112	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=64; weight (lbs.)=149; bmi=25.57; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin087_CSH_ESP-1125_087.d	ESP-1125	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=69; weight (lbs.)=234; bmi=34.55; MECFS=1; IBS=1
SUBJECT_SAMPLE_FACTORS           	Lipkin102_CSH_ESP-1138_088.d	ESP-1138	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=70; weight (lbs.)=208; bmi=29.84; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin079_CSH_ESP-1151_089.d	ESP-1151	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=65.5; weight (lbs.)=150.2; bmi=24.61; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin061_CSH_ESP-1164_090.d	ESP-1164	CaseStatus:Case | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=65; weight (lbs.)=177; bmi=29.45; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin090_CSH_ESP-1177_091.d	ESP-1177	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Overweight.Obese; height (in.)=63; weight (lbs.)=162.6; bmi=28.8; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin015_CSH_ESP-1190_092.d	ESP-1190	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=63; weight (lbs.)=130; bmi=23.03; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin026_CSH_ESP-1203_093.d	ESP-1203	CaseStatus:Case | SEX:Male | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=71; weight (lbs.)=215; bmi=29.98; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin052_CSH_ESP-1216_094.d	ESP-1216	CaseStatus:Control | SEX:Male | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=70; weight (lbs.)=172; bmi=24.68; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin098_CSH_ESP-1229_095.d	ESP-1229	CaseStatus:Control | SEX:Female | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=67; weight (lbs.)=139; bmi=21.77; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin030_CSH_ESP-1255_096.d	ESP-1255	CaseStatus:Case | SEX:Male | AGE_DICH:over50	BMI_DICH=Underweight.Normal; height (in.)=70; weight (lbs.)=168; bmi=24.1; MECFS=1; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin041_CSH_ESP-1268_097.d	ESP-1268	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=66.6; weight (lbs.)=170; bmi=26.94; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin084_CSH_ESP-1281_098.d	ESP-1281	CaseStatus:Control | SEX:Male | AGE_DICH:20_50	BMI_DICH=Overweight.Obese; height (in.)=68; weight (lbs.)=206; bmi=31.32; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin022_CSH_ESP-1294_099.d	ESP-1294	CaseStatus:Control | SEX:Female | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=66; weight (lbs.)=120; bmi=19.37; MECFS=-; IBS=-
SUBJECT_SAMPLE_FACTORS           	Lipkin010_CSH_ESP-1307_100.d	ESP-1307	CaseStatus:Control | SEX:Male | AGE_DICH:20_50	BMI_DICH=Underweight.Normal; height (in.)=76; weight (lbs.)=185; bmi=22.52; MECFS=-; IBS=-
#COLLECTION
CO:COLLECTION_SUMMARY            	Subjects included 50 cases and 50 controls from the Chronic Fatigue Initiative
CO:COLLECTION_SUMMARY            	(CFI) Cohort (28) recruited at 4 sites across the US who met the 1994 CDC Fukuda
CO:COLLECTION_SUMMARY            	and/or Canadian consensus criteria for ME/CFS.
CO:SAMPLE_TYPE                   	Blood
CO:BLOOD_SERUM_OR_PLASMA         	Plasma
#TREATMENT
TR:TREATMENT_SUMMARY             	Subjects included 50 cases and 50 controls from the Chronic Fatigue Initiative
TR:TREATMENT_SUMMARY             	(CFI) Cohort (28) recruited at 4 sites across the US who met the 1994 CDC Fukuda
TR:TREATMENT_SUMMARY             	and/or Canadian consensus criteria for ME/CFS.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	1.Thaw each 20 μL plasma aliquot at room temperature (see Aliquoting TEDDY
SP:SAMPLEPREP_SUMMARY            	samples SOP). Once thawed (~10min) place liquid plasma samples on ice. 2. Add
SP:SAMPLEPREP_SUMMARY            	225 μL cold “MeOH with QC mix” (see SOP “QC mix for LC-MS lipid
SP:SAMPLEPREP_SUMMARY            	analysis”). Keep MeOH on ice during extraction 3. Vortex each sample for 10s,
SP:SAMPLEPREP_SUMMARY            	keeping the rest on ice during all the extraction. 4. Add 750 μL of cold MTBE
SP:SAMPLEPREP_SUMMARY            	with 22:1 CE, keep MTBE on ice during extraction 5. Vortex for 10s 6. Shake for
SP:SAMPLEPREP_SUMMARY            	6min at 4°C in the orbital mixer. 7. Add 188 μL room temperature LC/MS grade
SP:SAMPLEPREP_SUMMARY            	water. 8. Vortex for 20 s 9. Centrifuge for 2 min @ 14,000 rcf (12300 rpm) 10.
SP:SAMPLEPREP_SUMMARY            	Remove supernatant, splitting into two aliquots of 350 μL, keeping one at
SP:SAMPLEPREP_SUMMARY            	–20°C for backup 11. Dry samples to complete dryness in the speed vacuum
SP:SAMPLEPREP_SUMMARY            	concentration system
SP:SAMPLEPREP_PROTOCOL_FILENAME  	SOP_Extraction_of_plasma.pdf
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 6550
CH:COLUMN_NAME                   	Waters Acquity CSH C18 (100 x 2.1mm, 1.7um)
CH:COLUMN_NAME                   	1.7um Pre-Column
CH:FLOW_GRADIENT                 	15% B to 99% B
CH:FLOW_RATE                     	0.6 mL/min
CH:COLUMN_TEMPERATURE            	65 C
CH:METHODS_FILENAME              	Data Dictionary Fiehn laboratory_CSH QTOF lipidomics_05-29-2014.pdf
CH:SOLVENT_A                     	60:40 Acetonitrile:Water +10mM Ammonium Acetate +10mM Acetic Acid
CH:SOLVENT_B                     	9:1 Isopropanol:Acetonitrile +10mM Ammonium Acetate +10mM Acetic Acid
CH:COLUMN_PRESSURE               	450-850 bar
CH:INJECTION_TEMPERATURE         	4 C
CH:INTERNAL_STANDARD             	See data dictionary
CH:RETENTION_TIME                	See data dictionary
CH:SAMPLE_INJECTION              	5.0 uL
CH:ANALYTICAL_TIME               	13 min
CH:CAPILLARY_VOLTAGE             	3500 eV
CH:TIME_PROGRAM                  	15 min
CH:WEAK_WASH_SOLVENT_NAME        	Isopropanol
CH:STRONG_WASH_SOLVENT_NAME      	Isopropanol
CH:TARGET_SAMPLE_TEMPERATURE     	Autosampler temp 4 C
CH:RANDOMIZATION_ORDER           	Excel generated
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:DETECTOR_TYPE                 	TOF MCP
AN:SOFTWARE_VERSION              	MassHunter
AN:DATA_FORMAT                   	.d
#MS
MS:MS_COMMENTS                   	-
MS:INSTRUMENT_NAME               	Agilent 6550 QTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:CAPILLARY_VOLTAGE             	3500 eV
MS:COLLISION_ENERGY              	40 eV
MS:COLLISION_GAS                 	Nitrogen
MS:DRY_GAS_FLOW                  	13L/min
MS:DRY_GAS_TEMP                  	200 C
MS:FRAGMENT_VOLTAGE              	175 eV
MS:FRAGMENTATION_METHOD          	Auto MS/MS
MS:ION_SOURCE_TEMPERATURE        	325 C
MS:ION_SPRAY_VOLTAGE             	1000
MS:IONIZATION                    	Neg
MS:PRECURSOR_TYPE                	Intact Molecule
MS:REAGENT_GAS                   	Nitrogen
MS:SOURCE_TEMPERATURE            	325 C
MS:DATAFORMAT                    	.d
MS:DESOLVATION_GAS_FLOW          	11 L/min
MS:DESOLVATION_TEMPERATURE       	350 C
MS:NEBULIZER                     	35 psig
MS:OCTPOLE_VOLTAGE               	750
MS:RESOLUTION_SETTING            	Extended Dyamic Range
MS:SCAN_RANGE_MOVERZ             	60-1700 Da
MS:SCANNING_CYCLE                	2 Hz
MS:SCANNING_RANGE                	60-1700 Da
MS:SKIMMER_VOLTAGE               	65
MS:MS_RESULTS_FILE               	ST000800_AN001272_Results.txt	UNITS:Counts
#END